Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.
NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial NCT07102888 is not yet recruiting, with estimated primary completion Feb 2026. No results or public readout available as of Apr 2026. No sources report any outcomes for this exact pediatric Phase 2 trial.
Found Apr 6, 2026, 2:57 PMReviewed Apr 6, 2026, 3:00 PM
NO_DECISIONDismissed95% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial NCT07102888 is not yet recruiting (est. primary completion 2026-02-01). No results or public readout exist. Prior Phase 1 in adults showed positive signals but is a different trial.
Found Apr 6, 2026, 2:08 PMReviewed Apr 6, 2026, 2:19 PM
NO_DECISIONDismissed90% confidencemanual-chat-review
Will the results be positive?
ClinicalTrials.gov still lists this study as not yet recruiting with no posted results, so there is not yet a clear public positive or negative trial readout.
Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:33 PM
NO_DECISIONDismissed97% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No public Phase 2 readout is evident for this exact trial. ClinicalTrials.gov lists NCT07102888 as not yet recruiting with no results posted and estimated primary completion in February 2026. Hengrui’s 2025 interim pipeline still shows RSS0393 in Phase II for plaque psoriasis without outcome language.
Found Apr 1, 2026, 6:47 PMReviewed Apr 1, 2026, 7:04 PM